Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Cetuximab After Immunotherapy for Head and Neck Cancer
Recruiting1 awardPhase 2
Winston-Salem, North Carolina
This trial will study if Cetuximab is an effective treatment for those who have failed or cannot tolerate other immuno-oncology treatments or immuno-oncology treatments combined with chemotherapy.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.